Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H22O8 |
Molecular Weight | 402.3946 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1OC)C2=CC(=O)C3=C(O2)C(OC)=C(OC)C(OC)=C3OC
InChI
InChIKey=MRIAQLRQZPPODS-UHFFFAOYSA-N
InChI=1S/C21H22O8/c1-23-13-8-7-11(9-15(13)24-2)14-10-12(22)16-17(25-3)19(26-4)21(28-6)20(27-5)18(16)29-14/h7-10H,1-6H3
Molecular Formula | C21H22O8 |
Molecular Weight | 402.3946 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:04:07 UTC 2023
by
admin
on
Sat Dec 16 19:04:07 UTC 2023
|
Record UNII |
D65ILJ7WLY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
4008 (Number of products:1)
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
NOBILETIN
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
DTXSID30197275
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
7602
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
618903
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
1467848
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
D65ILJ7WLY
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
72344
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
76751
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
478-01-3
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY | |||
|
300000032958
Created by
admin on Sat Dec 16 19:04:07 UTC 2023 , Edited by admin on Sat Dec 16 19:04:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
44% Cell growth rate of mouse myeloid leukemia M1 cells at 50 uM of compound vs control
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48% Cell growth rate of human acute promyelocytic leukemia HL-60 cells at 50 uM of compound vs control
|
||
|
TRANSPORTER -> INHIBITOR |
Decreased the IC50 value of paclitaxel by 15.92-fold. Restored the sensitivity of paclitaxel, doxorubicin, docetaxel, and daunorubicin in
ABCB1, overexpressing A2780/T and A549/T cells.
IC50
|